Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19: A Phase 2 Randomized Controlled Double-Blind Study by John Muscedere, MD, David M. Maslove, MD, MS, Christopher J. Barden, PhD, Donald F. Weaver, MD, PhD, J. Gordon Boyd, MD, PhD, Stephanie Sibley, MD, MS, Tracy Boyd, Oleksa Rewa, MD, MSc, Martin Albert, Marios Roussos, MD, MPH, Patrick A. Norman, MSc, Andrew G. Day, MSc, for the Canadian Critical Care Trials Group

Get full text